ScreenerHero

CDIO Cardio Diagnostics Holdings, Inc.

NAS · US · Healthcare · Biotechnology · cdio.ai
1.960USD-2.00%Mkt Cap: 5.80M $P/E: —

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap5.80M USD
Enterprise Value701.94K USD
Revenue (TTM)14.45K USD
Gross Profit14.45K USD
Net Income (TTM)-6.50M USD
Revenue/Share0.0060 USD
Last Price1.960 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.00
PEG—
EV/EBITDA-0.12
EV/Revenue48.58
P/S409.62
P/B0.80
EPS (TTM)-2.80
EPS (Forward)-0.25
52W Range
0.970014% of range7.910
52W High7.910 USD
52W Low0.9700 USD
Profitability
Gross Margin100.00%
Oper. Margin-27950.50%
EBITDA Margin0.00%
Profit Margin-43832.49%
ROE-93.19%
ROA-83.67%
Growth
Revenue Growth-28.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.73M USD
CapEx (TTM)419.31K USD
FCF Margin-26116.57%
FCF Yield-65.06%
Net Debt-5.22M USD
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.10
Current Ratio17.15
Quick Ratio15.56
Book Value/Sh2.51 USD
Cash/Share1.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.96M
Float2.84M
Insiders8.31%
Institutions6.52%
Short Interest
Short Ratio0.1d
Short % Float0.18%
Short % Out.0.18%
Shares Short5.26K
Short (prev mo.)29.57K
Technical
SMA 501.889 (+3.7%)
SMA 2002.167 (-9.5%)
Beta2.24
S&P 52W Chg16.45%
Avg Vol (30d)31.96K
Avg Vol (10d)26.87K
Technical Indicators
RSI (14)51.9
MACD0.0203
MACD Signal0.0192
MACD Hist.+0.0011
BB Upper2.088 USD
BB Middle1.966 USD
BB Lower1.844 USD
BB Width12.42%
ATR (14)0.1279 USD
Vol Ratio (20d)1.00x